375 related articles for article (PubMed ID: 1418887)
1. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
2. [Hematologic effects of clozapine: evaluation of the international experience].
Lamarque V
Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
[TBL] [Abstract][Full Text] [Related]
3. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
4. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
[TBL] [Abstract][Full Text] [Related]
5. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
6. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
[TBL] [Abstract][Full Text] [Related]
8. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
9. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
10. Agranulocytosis: incidence and risk factors.
Alvir JM; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
[TBL] [Abstract][Full Text] [Related]
11. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
12. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
Alfaro J; Berdichevsky E; Conte G; Tellez C
Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
[TBL] [Abstract][Full Text] [Related]
13. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
Kane JM
Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
[TBL] [Abstract][Full Text] [Related]
15. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices.
Peacock L; Gerlach J
J Clin Psychiatry; 1994 Feb; 55(2):44-9. PubMed ID: 8077154
[TBL] [Abstract][Full Text] [Related]
16. [Atypical granulocytopenia in clozapine treatment].
Hohl U; Hoffmann-Richter U
Psychiatr Prax; 1993 Nov; 20(6):232-3. PubMed ID: 8310097
[No Abstract] [Full Text] [Related]
17. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
Schulte P
Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
[TBL] [Abstract][Full Text] [Related]
18. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
[TBL] [Abstract][Full Text] [Related]
19. [Clozapine: an exclusive treatment?].
Vanelle JM
Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
[TBL] [Abstract][Full Text] [Related]
20. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
Honigfeld G
Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]